HIGHLIGHTS
- who: Established tumors are complex et al. from the Johns Hopkins University, Orleans Street, Rm409, Cancer Research Building, Baltimore, MD, USA have published the Article: Focus on the target: the tumor microenvironment, Society for Immunotherapy of Cancer Annual Meeting Workshop, October 24th-25th, in the Journal: (JOURNAL)
- what: This study demonstrated that 200mg/m2 CY and 35mg/m2 DOX were able to maximally induce HER2-specific antibody responses, while maintaining the HER-2-specific DTH response. The research presented at the 2012 SITC Workshop highlighted a rapidly growing appreciation for the complexities of the tumor . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.